<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01980433</url>
  </required_header>
  <id_info>
    <org_study_id>P121105</org_study_id>
    <nct_id>NCT01980433</nct_id>
  </id_info>
  <brief_title>Inhibitory rTMS in Dystonic Wilson Patients</brief_title>
  <acronym>WILSTIM</acronym>
  <official_title>Study of Writing Improvement in Patients With Wilson Disease and Dystonia After One Session of Inhibitory Repetitive Transcranial Magnetic Stimulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Wilson disease is a genetic disorder resulting in copper accumulation in liver, brain and&#xD;
      eye. The neurologic complications include dystonic syndrome, which is a prolonged and&#xD;
      excessive muscle activation responsible for abnormal postures. Hand dystonia prevents daily&#xD;
      life activities such as writing, which is particularly disabling, since writing is the only&#xD;
      mean of communication in these patients with significant slurred speech. Treatment is limited&#xD;
      and only partially effective.&#xD;
&#xD;
      Low frequency (&lt;or=1Hz) repetitive transcranial magnetic stimulation (rTMS) has shown&#xD;
      inhibiting properties when applied over the cortex. Since dystonia has been correlated to&#xD;
      hyperactivation of the neurons of the somatosensory cortex (SSC), we hypothesize that one&#xD;
      single 20-minute session of 1 Hz rTMS applied on left SSC will improve writing of the right&#xD;
      dystonic hand, assessed immediately at the end of the session.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study investigates the handwriting performance of an homogeneous cohort of patients with&#xD;
      Wilson disease and right handed dystonia, after one single inhibitory repetitive transcranial&#xD;
      magnetic stimulation (rTMS). Fifteen patients with focal right hand dystonia will receive&#xD;
      randomly either active or sham rTMS (1 Hz) to the left somatosensory cortex (SSC) in one&#xD;
      single 20 minutes session. Handwriting performance will be measured immediately after this&#xD;
      unique session (Visual analogic scale of subjective discomfort in writing, DPRE and WCRS&#xD;
      scales, pen pressure and pen velocity measured on touchpad), compared to scores obtained 24&#xD;
      hours before the session. Three days later, the patient will receive the other session (sham&#xD;
      rTMS or active rTMS) and the same parameters will be evaluated.&#xD;
&#xD;
      This is a single-center, randomized, crossover, prospective, clinical and double-blind study&#xD;
      (the rTMS session is performed by the neurophysiologist, but the patient and the neurologist&#xD;
      who will perform the handwriting evaluation are blind to the session).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2014</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>immediate and significant improvement in writing</measure>
    <time_frame>up to 1 week</time_frame>
    <description>Improvement of handwriting performance immediately after one single 20 minutes session of inhibitory (1 Hz) repetitive transcranial magnetic stimulation over the left somatosensory cortex.&#xD;
quantitative test score of writing WCRS&#xD;
Active or sham stimulation will be randomly assigned to the patient and the other session will be performed 3 days later.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>significant improvement in writing</measure>
    <time_frame>up to 1 week</time_frame>
    <description>improvement of other quantitative test scores of writing (VAS subjective discomfort writing, DPRE scales and parameters measured on touchpad) after a single session of 1 Hz rTMS inhibitory to the left CSS , compared to the scores achieved in the 24 hours before the session of rTMS.&#xD;
Active or sham stimulation will be randomly assigned to the patient and the other session will be performed 3 days later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>improvement of dystonia on the scale WDRS</measure>
    <time_frame>up to 1 week</time_frame>
    <description>Assessing the improvement of dystonia on the scale WDRS after a single session of 1 Hz rTMS inhibitory to the left CSS, compared to the scores achieved in the 24 hours before the session of rTMS.&#xD;
Active or sham stimulation will be randomly assigned to the patient and the other session will be performed 3 days later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>correlation between the scores and the other parameters of disease severity</measure>
    <time_frame>up to 1 week</time_frame>
    <description>Assess whether age, disease duration and the presence of cortical atrophy are inversely correlated with the evolution of scores.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Wilson Disease</condition>
  <condition>Movement Disorders</condition>
  <condition>Repetitive Transcranial Magnetic Stimulation</condition>
  <arm_group>
    <arm_group_label>Active rTMS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Repetitive Transcranial Magnetic stimulation: 1 Hz rTMS, delivered to left somatosensory cortex during rest. Intervention is delivered during 20 minutes in one single session.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham rTMS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Placebo Transcranial Magnetic stimulation delivered to left somatosensory cortex during rest. Intervention is delivered during 20 minutes in one single session.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Repetitive Transcranial Magnetic Stimulation (rTMS)</intervention_name>
    <description>Inhibitory 1 Hz rTMS, delivered to left somatosensory cortex during rest. Intervention is delivered during 20 minutes in one single session.</description>
    <arm_group_label>Active rTMS</arm_group_label>
    <arm_group_label>Sham rTMS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>pre and post-rTMS electroencephalogram</intervention_name>
    <description>to verify the absence of infraclinical seizures</description>
    <arm_group_label>Active rTMS</arm_group_label>
    <arm_group_label>Sham rTMS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>WCRS</intervention_name>
    <description>Writer's cramp rating scale</description>
    <arm_group_label>Active rTMS</arm_group_label>
    <arm_group_label>Sham rTMS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>handwriting scale DPRE</intervention_name>
    <description>handwriting in development and being evaluated by the NRC Wilson</description>
    <arm_group_label>Active rTMS</arm_group_label>
    <arm_group_label>Sham rTMS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>visual analog scale of discomfort writing and parameters collected on touchpad</intervention_name>
    <arm_group_label>Active rTMS</arm_group_label>
    <arm_group_label>Sham rTMS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Wilson disease with focal right hand dystonia&#xD;
&#xD;
          -  No modification of medical treatment for 6 months&#xD;
&#xD;
          -  No botulinum toxin administration within the past four months&#xD;
&#xD;
          -  Right handed&#xD;
&#xD;
          -  Focal right hand dystonia&#xD;
&#xD;
          -  Cerebral Magnetic Resonance performed the last 6 months with no other lesion than met&#xD;
             in Wilson disease&#xD;
&#xD;
          -  Over 18&#xD;
&#xD;
          -  Insurance policy holder&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant woman&#xD;
&#xD;
          -  Guardianship procedure&#xD;
&#xD;
          -  Seizure history&#xD;
&#xD;
          -  Other cerebral lesions on cerebral MRI than met in Wilson Disease&#xD;
&#xD;
          -  Unable to stay quiet for 30 minutes&#xD;
&#xD;
          -  Handwriting impossible&#xD;
&#xD;
          -  Contra-indications to repetitive Transcranial Magnetic Stimulation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nathalie KUBIS, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Physiology Department, Lariboisière Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean-Marc TROCELLO, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Neurology, Lariboisière Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Lariboisiere</name>
      <address>
        <city>Paris</city>
        <state>Ile De France</state>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>October 24, 2013</study_first_submitted>
  <study_first_submitted_qc>November 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2013</study_first_posted>
  <last_update_submitted>June 14, 2021</last_update_submitted>
  <last_update_submitted_qc>June 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Wilson disease</keyword>
  <keyword>Dystonia</keyword>
  <keyword>Movement Disorders</keyword>
  <keyword>Handwriting</keyword>
  <keyword>Repetitive Transcranial Magnetic Stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatolenticular Degeneration</mesh_term>
    <mesh_term>Movement Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

